ciba-geigy ltd. and chiron corp. said_0 they extended their offer for connaught biosciences inc. , valued_at 866 million_canadian dollars_-lrb- us$ 736 million -rrb- to oct._27 . the companies earlier said_0 they_did n't_want to raise their offer to match a rival bid by institut_merieux s.a. of c$ 37 a_share , or c$ 942 million . but they said_0 the c$ 30-a-share bid , which was due to expire monday , may still be extended or varied . merieux , a vaccine manufacturer based in lyon , france , is 51%-held by french state-owned rhone-poulenc s.a . ciba-geigy is a major pharmaceutical_concern based in basel , switzerland . chiron , another pharmaceutical_concern , is based in emeryville , calif . connaught is a biotechnology research and vaccine manufacturing concern . institut_merieux 's bid for toronto-based connaught has run_into problems with the canadian_government , which told merieux last_week that it was n't convinced that the proposed_acquisition would_be of `` net benefit '' to canada . merieux officials are_expected to meet with federal officials in ottawa today to_discuss the decision .